Lazard Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.51M | Hold |
|
|||||
|
2023
Q4 | $2.48M | Hold |
|
|||||
|
2023
Q3 | $2.29M | Sell |
|
|||||
|
2023
Q2 | $2.51M | Hold |
|
|||||
|
2023
Q1 | $2.58M | Hold |
|
|||||
|
2022
Q4 | $2.63M | Hold |
|
|||||
|
2022
Q3 | $2.53M | Hold |
|
|||||
|
2022
Q2 | $2.64M | Hold |
|
|||||
|
2022
Q1 | $3.06M | Hold |
|
|||||
|
2021
Q4 | $3.56M | Hold |
|
|||||
|
2021
Q3 | $3.85M | Sell |
|
|||||
|
2021
Q2 | $4.38M | Hold |
|
|||||
|
2021
Q1 | $4.03M | Hold |
|
|||||
|
2020
Q4 | $4.04M | Hold |
|
|||||
|
2020
Q3 | $3.59M | Buy |
|
|||||
|
2020
Q2 | $3.46M | Buy |
|
|||||
|
2020
Q1 | $659K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $3.06M | Hold |
|
|||||
|
2013
Q3 | $2.88M | Sell |
|
|||||
|
2013
Q2 | $2.68M | Buy |
|